This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrera, G.
Right arrow Articles by Piazzon, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrera, G.
Right arrow Articles by Piazzon, I.

 Previous Article  |  Next Article 

Journal of Virology, August 2008, p. 7422-7431, Vol. 82, No. 15
0022-538X/08/$08.00+0     doi:10.1128/JVI.00102-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Early Increases in Superantigen-Specific Foxp3+ Regulatory T Cells during Mouse Mammary Tumor Virus Infection{triangledown} ,{dagger}

Gabriel Cabrera,1,{ddagger} Dalia Burzyn,1,{ddagger} Juliana Mundiñano,1 M. Cecilia Courreges,2 Gabriela Camicia,1 Daniela Lorenzo,1 Héctor Costa,1 Susan R. Ross,2 Irene Nepomnaschy,1 and Isabel Piazzon1*

Instituto de Leucemia Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, División Medicina Experimental, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina,1 Department of Microbiology and Abramson Family Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania2

Received 15 January 2008/ Accepted 12 May 2008


arrow
ABSTRACT
 
Mouse mammary tumor virus (MMTV) is a milk-borne betaretrovirus that has developed strategies to exploit and subvert the host immune system. Here, we show in a natural model of MMTV infection that the virus causes early and progressive increases in superantigen (SAg)-specific Foxp3+ regulatory T cells (Treg) in Peyer's patches (PP). These increases were shown to be dependent on the presence of dendritic cells. CD4+ CD25+ T cells from the PP of infected mice preferentially suppress the proliferative response of T cells to SAg-expressing antigen-presenting cells ex vivo. We investigated the influence of the depletion of CD25+ cells at different stages of the infection. When CD25+ cells were depleted before MMTV infection, an increase in the number of PP SAg-cognate Foxp3 T cells was found at day 6 of infection. Since the SAg response is associated with viral amplification, the possibility exists that Treg cells attenuate the increase in viral load at the beginning of the infection. In contrast, depletion of CD25+ cells once the initial SAg response has developed caused a lower viral load, suggesting that at later stages Treg cells may favor viral persistence. Thus, our results indicated that Treg cells play an important and complex role during MMTV infection.


arrow
INTRODUCTION
 
Mouse mammary tumor virus (MMTV) is a betaretrovirus transmitted through milk that causes mammary tumors in mice (7, 32). The MMTV infection model has provided a valuable tool to study how a pathogen can take advantage of the host immune system, and several strategies of virus-host exploitation have been described for this virus (reviewed in references 1 and 13). In neonatal Peyer's patches (PP), MMTV is thought to infect antigen presenting cells (APCs), which then present a virus-encoded superantigen (SAg) to T cells expressing SAg-specific T-cell receptor Vβ chains (9). The resulting interaction is critical since it leads to the amplification of infection in lymphoid cells and induces the proliferation of infected B cells (21). Infected lymphocytes then carry MMTV to the mammary gland, allowing the virus to be passed to the next generation (1, 13). In addition, it has been demonstrated that MMTV interacts with Toll-like receptor 4 (38), and we have shown that this interaction induces recruitment of dendritic cells (DCs) to the PP and increases the expression of the MMTV cell entry receptor on DCs in vivo (8). We have also reported that DCs are capable of producing infectious virus that can be transmitted to other cell types (11). It has also been reported that MMTV can subvert the host immune system by inducing Toll-like receptor 4-dependent secretion of interleukin-10 by splenic B cells (24). However, the involvement of Foxp3+ regulatory T (Treg) cells during MMTV infection has not been studied.

Since the CD4+ CD25+ T-cell population with regulatory capacity was characterized in 1995 (42), numerous reports have postulated the existence of different subsets of regulatory cells (43). The transcription factor Foxp3 is currently considered the most selective marker for CD4+ CD25+ Treg cells (27, 53). CD4+ CD25+ Foxp3+ cells develop either in the thymus or in the periphery and are called "natural" or "adaptive" Treg cells, respectively. Natural Treg cells migrate from the thymus and constitute 5 to 10% of peripheral CD4+ T cells in mice, while adaptive Treg cells are converted from CD4+ CD25 Foxp3 T cells under appropriate conditions (43). To date, there is a lack of specific markers to distinguish between these two populations. The T-cell receptor specificity of Treg cells has been controversial since their initial characterization. At first it was assumed that these cells recognized self-antigens, but accumulating evidence suggests that Treg cells are involved in responses to foreign antigens and may function to keep immune responses in check after initial recognition of such antigens (2, 6, 28, 45). In support of this, it has been recently reported that non-self antigens are the cognate specificities of Foxp3+ Treg cells (36). The specificity of Treg cells with regard to their suppressor-effector function is another debated issue. While initial reports postulated that Treg cells activated through their T-cell receptor suppressed immune responses in a nonspecific manner, recent studies suggest that these cells may suppress with specificity both in vivo and in vitro (23, 34, 35, 49).

Recent reports have suggested that Treg-cell induction may be a strategy used by some pathogens to establish and maintain infection (6, 14, 30, 31, 40, 46). As MMTV is known to exploit the immune system, the aim of this study was to investigate whether MMTV causes early alterations in PP CD4+ Foxp3+ Treg populations and to determine the role of these cells during milk-borne MMTV infection.


arrow
MATERIALS AND METHODS
 
Mice. The following strains of mice were used: BALB/cJ (H-2d Mtv7) mice; MMTV(LA)-infected BALB/cJ mice (20) carrying three different MMTV exogenous viruses, BALB6, BALB2, and BALB14, encoding SAgs with major specificities for Vβ6, Vβ2, and Vβ14 T cells, respectively; MMTV(BALB6)-infected BALB/cJ mice; C3H/HeN (H-2k Mtv-7) mice; and AKR/J (H-2k Mtv-7+) mice. Mice were bred in the animal facility of the Instituto de Leucemia Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina. CD11c-DTR mice [C.FVB-Tg (Itgax-DTR/EGFP) 57Lan/J] (25), originally obtained from Dan Littman, were maintained by crossing with BALB/cJ mice at the University of Pennsylvania, Philadelphia, PA. The mice were housed according to the policies of the University of Pennsylvania and Academia Nacional de Medicina (NIH Guide for the Care and Use of Laboratory Animals) (33). Mtv-7+ and Mtv-7 mice were generated by crossing (BALB/cJ x AKR/J)F1 x BALB/cJ mice, and their phenotype was determined by fluorescence-activated cell sorting (FACS) analyzing the presence or absence of Vβ6+ T cells. These mice were nursed on MMTV(BALB6)-infected females.

Experimental model. Eight-day-old mice were foster nursed on MMTV-infected mothers for the days indicated in the text or in the figures. The mice were sacrificed, their PP were dissected, and single-cell suspensions were prepared by homogenization through a stainless steel mesh. The cells were washed once with RPMI medium-10% fetal bovine serum. FACS analysis was performed as described below.

DC depletion and infection of CD11c-DTR mice. For systemic DC depletion, CD11c-DTR transgenic mice were injected intraperitoneally with 4 ng/g of body weight diphtheria toxin (DT) (Sigma Chemical Co., St. Louis, MO) 1 day prior to injection with virus.

Virus preparation. MMTV(LA) (20) was isolated from tumor tissue, as previously described (19). Dilutions of purified virus were tested for B-cell and SAg-mediated T-cell activation in vivo, as previously described (20). The maximum dilution of virus giving significant activation in the draining versus nondraining lymph node was used in all the experiments. Fifty microliters of diluted MMTV(LA) virus stock was injected into the right-hind footpad of mice; the left hind footpad served as the uninfected control.

Flow cytometry. Cells were incubated with Fc-{gamma} block antibody (anti-mouse CD16/32; Pharmingen, San Diego, CA) to prevent nonspecific binding of antibodies to Fc-{gamma} receptors. Cells (1 x 106) were stained with the following monoclonal antibodies (Pharmingen) and subjected to FACS analysis: fluorescein isothiocyanate (FITC) or Cy-chrome 5-conjugated anti-CD4 (clone H129.19), allophycocyanin-conjugated anti-CD4 (clone RM4-5), FITC or peridinin chlorophyll protein-conjugated anti-CD25 (clones 7D4 and PC61, respectively), FITC-conjugated anti-Vβ6 (clone RR4-7), and FITC-conjugated anti-Vβ10 (clone B21.5). Intracellular staining of Foxp3 was performed using phycoerythrin-conjugated anti-Foxp3 and the Foxp3 staining buffer set (e-Bioscience) according to the manufacturer's protocol. Cells were acquired on a FACScan or FACSaria cytometer (Becton Dickinson, Mountain View, CA). Data were analyzed by using CELLQUEST software (Becton Dickinson Immunocytometry Systems).

MLR. Mixed lymphocyte reactions (MLR) were performed in round-bottom 96-well culture plates (Corning Costar, Cambridge, MA) by coculturing the following cells purified by magnetic cell sorting beads (Miltenyi Biotec, Germany) according to the manufacturer's protocol for 4 days: 2 x 105 BALB/cJ CD4+ CD25 cells (responders) labeled with 5,6-carboxifluorescein diacetate succinimidyl ester (CFSE) (Molecular probes, Eugene, OR) and 2 x 105 mitomycin C-treated mononuclear spleen cells from AKR/J or C3H/HeN mice (stimulators). CD4+ CD25+ or CD4+ CD25 cells obtained from PP of infected or uninfected pups were treated with mitomycin C (16), and different numbers of cells (0.5 x 105, 1.0 x 105, or 1.5 x 105) were added to the MLR mixtures from the beginning. Proliferation of CD4+ responder cells was analyzed by CFSE dilution.

Depletion of CD25+ cells. It has been previously shown that depletion of CD25 cells by anti-CD25 antibody (clone PC61) was short term and reversible (31). For depletion before MMTV infection, 2-day-old BALB/cJ mice were inoculated intraperitoneally (i.p.) for three successive days with 0.1 mg of anti-CD25 antibody (clone PC61); i.p. inoculation with isotype-matched rat monoclonal antibody was used as a control. At day 8 after birth, these mice were foster nursed for 15 days on MMTV(LA)-infected mothers.

For depletion during MMTV infection, 8-day old mice were foster nursed on MMTV(LA)-infected mothers for 6 days, and then half of the littermates were injected i.p. daily with 0.1 mg of anti-CD25 antibody from day 6 to day 8 of infection. These mice were used to compare MMTV infection levels between depleted and nondepleted 31-day-old mice and to cross with CD25-depleted littermates to obtain a second generation of mice. Half of the second generation of mice was depleted of CD25+ T cells from day 6 to day 8 of infection, and MMTV infection levels were compared between depleted and nondepleted 31-day-old mice. The efficiency of depletion was assessed by FACS using anti-CD25 antibody (clone 7D4). A 90% reduction in CD4+ CD25+ cells was achieved with these protocols.

Radioactive PCR. DNA was isolated from spleens and mesenteric lymph nodes of 23- to 31-day-old mice. Semiquantitative radioactive PCR analysis was carried out as follows. (i) For MMTV(LA) amplification, the PCR program consisted of 1 min at 94°C, 40 s at 60°C, and 1 min at 72°C for 38 cycles in PCR buffer containing 250 to 500 ng of DNA, 0.5 U Taq polymerase, 0.5 µCi of [{alpha}-32P]dATP, 10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, a 0.1 µM concentration of each primer, and a 0.2 mM concentration of each deoxynucleotide in a final volume of 50 µl. (ii) For β-actin amplification, the PCR program consisted of 1 min at 94°C, 60 s at 56°C, and 1 min at 72°C for 33 cycles in the same PCR buffer used for MMTV(LA) amplification. These conditions gave linear DNA amplification. The reactions were exponential up to 35 cycles for β-actin and 40 cycles for the virus before the beginning of the plateau (see supplemental material). The following primers were used: to detect virus, 5'-AATTCGGAGAACTCGACCTTCC-3' and 5'-CCCCCATGAGTATATTTGA-3'; to detect the mouse β-actin, 5'-TCATGAAGTGTGACGTTGACATC-3' and 5'-CCTAGAAGCATTTGCGGTGCAACGATG-3'. The PCR products were analyzed by gel electrophoresis in 30% acrylamide gels. The bands corresponding to virus and β-actin amplification were quantified using Scion Image software.

Statistical analysis. Levels of significance were determined using a two-tailed Student's t test, and a confidence level of greater than 95% (P < 0.05) was used to establish significance.


arrow
RESULTS
 
MMTV infection induces early increases in PP Foxp3+ Treg cells. In order to analyze alterations in the population of Treg cells in neonatal PP at early times after milk-borne MMTV infection, the expression of CD25 and Foxp3 in CD4+ T cells was studied. FACS analysis indicated that the percentage (data not shown) and absolute number of PP CD4+ CD25+ Foxp3+ Treg cells increased progressively in MMTV(LA)-infected mice during the first 2 weeks of infection (Fig. 1A and B). In addition, FACS analysis showed that CD4+ CD25 Foxp3+ T cells, which have been described either as proliferating Treg cells (18) or as a Treg cell reservoir (52), increased with trends similar to CD4+ CD25+ Foxp3+ Treg cells (Fig. 1C). Of interest, CD4+ CD25+ Foxp3 activated/effector T cells showed a significant increase in the percentage (data not shown) and absolute number at day 2 of infection and then diminished markedly from day 3 onwards (Fig. 1D). Finally, the CD4+ CD25 Foxp3 T-cell population also increased in percentage (data not shown) and absolute number during the first 2 weeks of infection (Fig. 1E), likely due to the recruitment of naive CD4+ T cells to PP that takes place during MMTV infection, as we have previously reported (12).


Figure 1
View larger version (38K):
[in this window]
[in a new window]

 
FIG. 1. Changes in PP CD4+ cell populations during the first 2 weeks of MMTV infection. BALB/cJ pups were foster nursed on MMTV(LA)-infected (black bars) or uninfected (gray bars) mothers. Expression of CD4, CD25, and intracellular Foxp3 in PP cells was analyzed by FACS at different days of infection. PP cells were gated for live cells in the forward-sideward scatter (B to E) and for CD4+ cells (A). Cell types are indicated on the y axes (B to E). Panel A shows representative dot plots of CD25 and Foxp3 expression in PP CD4+ cells at day 2 of infection. Data in panels B to E are expressed as means ± standard deviations (n = 4). *, P < 0.05. The experiment was performed three times with similar results.

These results indicate that MMTV infection induced progressive increases in both the CD4+ CD25+ Foxp3+ and CD4+ CD25 Foxp3+ populations of Treg cells at least during the first 2 weeks of infection. In contrast, CD4+ CD25+ Foxp3 activated/effector T cells significantly increased at day 2 of infection but then decreased and were maintained at a lower level from day 3 onward.

MMTV infection induces increases in SAg-specific Treg cells. The early response to the MMTV SAg results in an increase in the percentage of SAg-reactive Vβ-specific T-cell clones (26). We next addressed whether the Foxp3+ Treg cells that increased in the PP of MMTV-infected neonates were SAg specific. We used BALB/cJ pups infected with MMTV(BALB6), an exogenous virus whose SAg hypervariable region is identical to that of the Mtv-7 provirus and has primary specificity for Vβ6 T cells (20). We determined that Vβ6+ CD4+ CD25+ Foxp3+ SAg-specific Treg cells increased both in percentage and absolute number from day 2 to day 15 of infection. Figure 2A shows representative dot plots at day 15 of infection; Fig. 2B and C depict the percentages and the absolute numbers. In addition, Vβ6+ CD4+ CD25 Foxp3+ Treg cells showed increases with similar trends (Fig. 2D and E). Importantly, no significant changes were observed in Vβ10+ CD4+ CD25+ Foxp3+ (Fig. 2F and G) and Vβ10+ CD4+ CD25 Foxp3+ T cells (Fig. 2A) that were not stimulated by the MMTV(BALB6) SAg. On the other hand, SAg-specific CD4+ CD25+ Foxp3 activated/effector T cells increased in percentage and absolute number at day two of MMTV(BALB6) infection (Fig. 2I and J) and then decreased with kinetics similar to the total population of CD4+ CD25+ Foxp3 T cells (Fig. 1D).


Figure 2
View larger version (21K):
[in this window]
[in a new window]

 
FIG. 2. SAg specificity of PP Foxp3+ Treg cells during the first 2 weeks after MMTV infection. BALB/cJ pups were foster nursed on MMTV(BALB6)-infected (A to G and I and J) or MMTV(LA)-infected (H) (black bars) or uninfected (gray bars) mothers. Expression of Vβ6, CD4, CD25, and intracellular Foxp3 in PP cells was analyzed by FACS at different days after infection. PP cells were gated for live cells in the forward-sideward scatter (B to G and I and J) and for Vβ+ CD4+ cells (A and H). Cell types are indicated along the y axes (B to G and I and J). (A) Representative dot plots of CD25 and Foxp3 in PP Vβ6+ CD4+ and Vβ10+ CD4+ cells at day 15 of infection. (H) Percentage of Foxp3+ cells within Vβ6+ CD4+, Vβ14+ CD4+, and Vβ10+ CD4+ cells at day 15 of infection. Data are expressed as the means ± standard deviations (n = 4). *, P < 0.05. The experiments were performed three times with similar results.

Similar results were obtained using the MMTV(LA) virus which carries three different exogenous viruses: BALB6, BALB2, and BALB14 with primary specificities for Vβ6+, Vβ2+, and Vβ14+ T cells, respectively (20). Figure 2H shows representative results indicating that Treg cells were significantly overrepresented within the SAg-cognate but not in SAg-nonreactive T-cell populations during infection.

Taken together, these results showed that MMTV infection induced early and progressive increases in SAg-cognate Treg cells. In addition, since only SAg-reactive Treg cells showed significant increases, these data suggest that the increases in Treg cells were mainly due to increases in SAg-reactive T cells. To further confirm this, we employed neonatal mice in which MMTV(BALB6) SAg-reactive T cells were deleted by the presence of the endogenous Mtv-7 provirus. Mtv-7 and Mtv-7+ mice were generated as described in Materials and Methods and then foster nursed on MMTV(BALB6)-infected mothers for 6 days. Mtv-7 mice showed increases in the percentage and the absolute number of CD4+ CD25+ Foxp3+ and CD4+ CD25 Foxp3+ Treg cells, whereas Mtv-7+ mice showed no significant increases in these cell populations (Fig. 3). These results confirm that the increases in Treg cells that occurred during MMTV infection were mainly due to increases in SAg-reactive T cells.


Figure 3
View larger version (14K):
[in this window]
[in a new window]

 
FIG. 3. Increases in PP Treg cells are dependent on the presence of SAg-reactive T cells. Mtv-7+ and Mtv-7 mice generated by crossing (BALB/cJ x AKR/J)F1 x BALB/cJ mice were nursed on MMTV(BALB6)-infected or uninfected mothers for 6 days. The expression of CD4, CD25, and intracellular Foxp3 in PP cells was analyzed by FACS. PP cells were gated for live cells in the forward-sideward scatter. Cell types are indicated along the y axes. Data are presented as the means ± standard deviations (n = 5). *, P < 0.05. The experiment was performed four times with similar results.

Treg-cell increases are dependent on the presence of DCs. DCs play an important role in MMTV infection (8, 11). We recently showed that the SAg response is abrogated in the absence of these cells (11). To investigate whether DCs were involved in the MMTV-induced increase in Foxp3+ Treg cells, we used an in vivo model of inducible DC ablation, the CD11c-DTR mice (25). Administration of DT to CD11c-DTR mice produces a selective and temporal depletion of CD11c+ cells, generating conditional DC knockouts (25). Although ablation was successfully accomplished in adult mice, our attempts to adapt the model to neonatal mice failed because the DT was lethal for the transgenic pups, even in low doses. Therefore, we carried out these experiments in adult mice. We first tested whether MMTV also affected the CD4+ CD25+ Foxp3+ cell subset in an experimental model of footpad infection. When MMTV(LA) was injected subcutaneously into wild-type adult animals, the draining popliteal lymph node showed an increase in the percentages and absolute numbers of CD4+ CD25+ Foxp3+ and Vβ6+ CD4+ CD25+ Foxp3+ Treg cells, resembling the one observed in the PP (not shown). CD11c-DTR mice were injected i.p. with DT (day –1) and then with MMTV in the footpad (day 0), and the numbers of CD4+ CD25+ Foxp3+ and Vβ6+ CD4+ CD25+ Foxp3+ cells were analyzed in the draining and nondraining popliteal lymph nodes at 2 and 6 days after infection. DC depletion abolished increases in both the CD4+ CD25+ Foxp3+ Treg cells and the SAg-specific Treg cells (Fig. 4), thus demonstrating that the MMTV-induced increase in Treg cells was DC dependent.


Figure 4
View larger version (14K):
[in this window]
[in a new window]

 
FIG. 4. Increases in Treg cells are dependent on the presence of DCs. CD11c-DTR adult mice were injected i.p. with DT (day –1) and with MMTV(LA) in the footpad (day 0). After 2 or 6 days the expression levels of Vβ6, CD4, CD25, and Foxp3 were analyzed by FACS in the draining and nondraining (ND) popliteal lymph nodes. Lymph node cells were gated for mononuclear cells in the forward-sideward scatter. (A) Number of CD4+ CD25+ Foxp3+ cells in draining popliteal lymph nodes of mice treated with DT or not treated with DT and in nondraining popliteal lymph nodes (ND). (B) Number of Vβ6+ CD4+ CD25+ Foxp3+ cells in untreated (No DT) DT-treated lymph nodes and in nondraining (ND) lymph nodes. Data are presented as the means ± standard deviations (n = 3). *, P < 0,05. One experiment out of two is shown.

CD4+ CD25+ PP cells from infected mice preferentially suppress the proliferative response of T cells to SAg-expressing APCs. MLR assays are commonly used to test the suppressive activity of Treg cells. For the MLR assays, we purified CD4+ CD25+ cells from the PP of BALB/cJ mice foster nursed for 6 days on MMTV(LA)-infected mothers in order to evaluate their ability to suppress responses ex vivo. We performed the MLR assays by coculturing CFSE-labeled BALB/cJ CD4+ CD25 cells (responders) with mitomycin C-treated mononuclear spleen cells from AKR/J mice (stimulators). CD4+ CD25+ or CD4+ CD25 cells obtained from the PP of infected or uninfected pups were added to the MLR mixture from the beginning of the culture. Proliferation of CD4+ responder cells was analyzed by CFSE dilution. As shown in Fig. 5, PP CD4+ CD25+ cells from infected mice strongly inhibited proliferation in the MLR assay using AKR/J APCs and suppressed the proliferative response more efficiently than CD4+CD25+ cells from uninfected littermates. In addition, the percentage of inhibition increased in a dose-dependent manner (data not shown). These results indicate that CD4+ CD25+ cells obtained from the PP of infected mice had a strong immunosuppressive activity when AKR/J APCs were used in the MLR assays. In addition, the suppressive capacity of these cells was greater than that of CD4+ CD25+ cells from uninfected mice.


Figure 5
View larger version (25K):
[in this window]
[in a new window]

 
FIG. 5. CD4+ CD25+ cells from PP of MMTV-infected mice are more potent at suppressing the proliferative response of T cells to SAg-expressing APCs. MLR were performed by coculturing CFSE-stained BALB/cJ CD4+ CD25 responder cells with mitomycin C-treated mononuclear spleen cells from AKR/J (Mtv-7+) mice or C3H/HeN (Mtv-7) stimulators. CD4+ CD25+ or CD4+ CD25 cells (1.5 x 10–5) obtained from the PP of uninfected pups or those infected for 6 days with MMTV(LA) were added to the MLR mixture from the beginning. Proliferation of CD4+ responder cells was analyzed by CFSE dilution. (A) Representative histogram plots. Except for panel a, where the culture contained only responding cells, PP cells were added to responding and presenting cells as follows: b, none; c, CD4+ CD25+ cells from MMTV-positive mice; d, CD4+ CD25 cells from MMTV-positive mice; e, CD4+ CD25+ cells from MMTV-negative mice; f, CD4+ CD25 cells from MMTV-negative mice. (B) Percent inhibition of proliferation observed in MLR; the CD4+ cells added in each case are shown on the x axis. Data are presented as the means ± standard deviations (n = 3). One experiment out of four is shown.

Recognition of SAgs by T cells is major histocompatibility complex (MHC) dependent but not MHC restricted (44). The magnitude of the proliferative response of the BALB/cJ (H-2d) CD4+ T cells to AKR/J (H-2k Mtv-7+) APCs is mainly due to the SAg encoded by the Mtv-7 provirus formerly known as Mls-1a (22). MMTV(LA) includes a virus whose SAg hypervariable region is identical to that of the Mtv-7 provirus. To test whether PP CD4+ CD25+ T cells purified from MMTV(LA)-infected mice preferentially suppressed the proliferative response of T cells to SAg-expressing APCs, we performed MLR assays with stimulator cells from spleens of AKR/J (H-2k Mtv-7+) or C3H/HeN (H-2k Mtv-7) mice. CD4+ CD25+ T cells from uninfected mice inhibited the response to C3H/HeN or AKR/J APCs to the same extent. In addition, CD4+ CD25+ T cells from MMTV(LA)-infected and noninfected mice suppressed the response to C3H/HeN APCs to the same extent. However, the immunosuppressive activity of MMTV(LA)-infected PP CD4+ CD25+ cells was higher upon AKR/J stimulated T-cell proliferation than with C3H/HeN stimulation (Fig. 5). Thus, results reported herein suggest that CD4+ CD25+ T cells from infected mice preferentially suppressed the proliferative response of T cells to SAg-expressing APCs.

Effects of the depletion of CD25+ cells before MMTV infection. The early response to the MMTV SAg has been associated with viral amplification (1, 13). In order to investigate changes in the SAg response in the absence of Treg cells, we depleted mice of CD25+ cells before foster-nursing them for 6 days on MMTV(LA)-infected mothers as described in Materials and Methods. CD25-depleted mice showed a significant increase in the number of responding PP Vβ6+ CD4+ Foxp3 T cells at day 6 of infection (Fig. 6A).


Figure 6
View larger version (20K):
[in this window]
[in a new window]

 
FIG. 6. Effects of the depletion of CD25+ cells during MMTV infection.(A) BALB/cJ mice were depleted of CD25+ cells before infection and foster nursed on MMTV(LA)-infected females from day 8 to day 14, when they were sacrificed. Expression of Vβ6, CD4, and intracellular Foxp3 in PP cells was analyzed by FACS. PP cells were gated for live cells in the forward-sideward scatter. Shown are the number of Vβ6+ CD4+ Foxp3 cells. Data are presented as the means ± standard deviations (n = 4). *, P < 0.05. The experiment was performed two times with similar results. (B) BALB/cJ mice were depleted of CD25+ cells before MMTV infection as described in Materials and Methods and foster nursed for 15 days on MMTV(LA)-infected females from day 8 to day 23, when they were sacrificed. DNA from the mesenteric lymph nodes was extracted, and radioactive semiquantitative PCR was performed. The figure shows a representative virus and β-actin amplification in three individual nondepleted and depleted mice each. (C) Quantification of virus amplification relative to β-actin was performed with the software Scion Image. One experiment out of five is shown. (D) Eight-day-old mice were nursed on MMTV(LA)-infected females for 6 days. At this time, mice were depleted of CD25+ cells by three successive i.p. injections of anti-CD25 antibody from day 6 to day 8 of infection. The female mice were bred, and half of their neonatal offspring were depleted of CD25+ cells in a similar manner. Thirty-one-day-old mice were sacrificed, DNA was extracted from spleen, and radioactive semiquantitative PCR was performed. The figure shows a representative virus and β-actin amplification in four nondepleted and three depleted mice. (E) Quantitation of virus amplification relative to β-actin was performed with the software Scion Image. The experiment was performed five times with similar results.

To determine whether Treg cells affected virus load early during infection, we depleted mice of CD25+ cells before foster-nursing them for 15 days on MMTV(LA)-infected mothers as described in Materials and Methods. The mice were sacrificed at the age of 23 days, DNA was extracted from the mesenteric lymph nodes and spleens, and MMTV integration was studied by radioactive PCR. Figure 6B shows representative results obtained using mesenteric lymph nodes, and Fig. 6C shows the gel quantitation. Mice with CD25+ cell depletion contained at least two times more viral DNA sequences in both organs than nondepleted mice. This difference was small but highly reproducible. Taken together, these results raise the possibility that Treg cells—by attenuating the SAg response—play a role in decreasing viral load at the beginning of MMTV infection.

Depletion of CD25+ cells once the initial SAg response has developed causes lower MMTV viral load. To determine the role of Treg cells once the initial SAg response has occurred, we depleted mice of CD25+ T cells from day 6 to day 8 of infection, i.e., after the CD4+ CD25+ Foxp3 cells had returned to almost basal levels and the CD4+ CD25+ cells were mostly Foxp3+ Treg cells (Fig. 1). The experiments were performed employing two successive generations of mice. Half of the MMTV(LA)-infected littermates were depleted of CD25+ cells as described in Materials and Methods from day 6 to day 8 of infection, and then these mice were either sacrificed at 31 days to evaluate viral load in the first generation or crossed with BALB/cJ males to obtain a second generation. Half of the second generation was also depleted of CD25+ cells for 3 days (day 6 to day 8 of infection). DNA was extracted from the mesenteric lymph nodes and spleens of 31-day-old mice, and radioactive PCR was performed. A slight decrease in viral load was observed in the first generation of depleted mice (not shown). However, a marked decrease in viral load at the second generation was seen. In this case, the CD25 T-cell-depleted mice contained at least 10-fold less viral DNA in both organs than nondepleted littermates (Fig. 6D and E). These results suggested that after the initial suppression of SAg-mediated T-cell stimulation, Treg cells play a role in increasing viral load.


arrow
DISCUSSION
 
The final outcome of an infectious process is influenced by characteristics of both the pathogen and the host immune system. In addition to a well-described number of strategies to evade the immune response, it has been recently reported that some pathogens are able to take advantage of Treg cells to establish infection (14, 30, 31, 40, 46). In particular, the persistence of some retroviral infections, such as feline immunodeficiency virus, human immunodeficiency virus (HIV), and Friend murine leukemia virus infection, has been correlated with increases in Treg cells (4, 5, 46, 49). Here, we investigated whether MMTV infection induces alterations in the population of PP CD4+ Foxp3+ Treg cells during early steps of natural milk-borne infection.

Our results showed that MMTV induced early and progressive increases in the number of CD4+ CD25+ Foxp3+ Treg cells in PP, at least during the first 2 weeks of infection. In addition, we showed that CD4+ CD25 Foxp3+ cells, which have been described either as proliferating Treg cells (18) or as a Treg-cell reservoir (52), increased with kinetics similar to that of CD4+ CD25+ Foxp3+ cells. The increases in Foxp3+ cells may be due to recruitment of natural Foxp3+ Treg cells (45), conversion of Foxp3 to Foxp3+ T cells (10, 29), and/or proliferation of natural or converted Foxp3+ T cells (48).

It has been reported that natural Treg cells are significantly exported to the periphery only after day 3 of postnatal life (3) and that 3-day old mice already contain Foxp3-expressing CD4+ CD25+ splenocytes (15). However, there are no data in the literature regarding Treg cells in the PP of neonatal mice. Thus, the possibility exists that natural Treg cells are absent in PP during the first days of life. As in our experimental model we began the foster nursing at day 8 of life, we also foster nursed mice from birth to validate our model. Similar increases in the levels of Treg cells were observed after 15 days of infection (data not shown), thus validating the results of our experimental system.

Accumulating evidence suggests that CD4+ CD25+ Treg cells are able to recognize exogenous antigens derived from microbes, parasites, and allogeneic tissues (2, 6, 31, 45). It is well-known that viral and bacterial SAgs induce increases in CD4 T cells bearing specific receptor Vβ chains (26), but little is known about the involvement of SAg-specific Foxp3+ Treg cells in these increases (17). In an adult model of MMTV(SW) infection, a population of CD4+ Vβ6+ CD25+ cells that remained constant in absolute number throughout the adult life was described. It was suggested that these cells could have a regulatory role during MMTV infection although neither their functionality nor the expression of Foxp3 was examined (37). In addition, it has been reported that when CD4+ CD25+ Treg cells isolated from BALB/c mice were transferred to BALB/c nude mice with DBA/2 (Mtv-7+) skin grafts, an increase in the percentage and number of Vβ6+ cells within the transferred CD4+ cell population was observed (35). The experiments performed in our model of natural MMTV infection showed that PP SAg-reactive CD4+ CD25+ Foxp3+ and CD4+ CD25 Foxp3+ Treg cells increased progressively in percentages and absolute numbers from day 2 onward. No increases were detected in Treg cells that did not respond to the SAgs encoded by the MMTVs used in these experiments. In addition, SAg-specific activated/effector CD4+ CD25+ Foxp3 T cells increased at day 2 of infection but then were maintained at lower levels from that day onward. As this decrease correlated kinetically with the increase in SAg-specific Treg cells, we hypothesize that Treg cells were responsible for the decrease in the number of activated/effector T cells.

Importantly, our results indicated that the Treg populations that increased in the PP during MMTV infection not only were able to recognize a foreign antigen, in this case the viral SAg, but also were mainly comprised of SAg-cognate T cells. Further reinforcing this notion, our results showed that infection of neonatal mice in which SAg-reactive T cells were deleted by the presence of an endogenous provirus did not induce alterations in Foxp3+ Treg cells, indicating that the increase in Treg cells that occurred during MMTV infection were due mainly to increases in SAg-cognate T cells.

DCs play a pivotal role in the immune system, and it is becoming evident that these cells are involved in the expansion of Treg cells (28, 51). For example, it has been shown that infected DCs can lead to an expansion of Treg cells during Friend murine leukemia virus infection (4). We recently showed the importance of DCs during MMTV infection, demonstrating that these are the first targets of MMTV infection in vivo and that the SAg-mediated T-cell response is abrogated in absence of this population (11). Supporting the importance of the SAg response, we showed here that the early increases in Foxp3+ Treg cells were also completely abrogated in absence of DCs. Thus, the increase in Treg cells that occurred in response to MMTV infection was likely due to SAg presentation by infected DCs to cognate T cells.

Despite the increasing number of studies concerning Treg cells, the antigen specificity of their suppressor-effector function remains a debated issue. At first it was thought that Foxp3+ Treg cells suppressed without specificity, but there is recent evidence showing that Treg cells induced during certain allogeneic responses are able to suppress in an antigen-specific manner (23, 50). It has also been reported that Treg cells induced during HIV infection are more effective at regulating HIV p24-specific responses than other unrelated immune responses in the same patients (49).

MMTV(LA) includes a virus whose SAg hypervariable region is identical to that of the Mtv-7 provirus. The use of AKR/J (H-2k Mtv-7+) and C3H/HeN (H-2k Mtv-7) APCs allowed us to investigate the specificity of the suppressor-effector function of PP Treg cells from MMTV(LA)-infected mice. CD4+ CD25+ T cells from noninfected mice did not distinguish between AKR/J and C3H/HeN APCs. Importantly, PP CD4+ CD25+ cells from infected mice showed greater suppression of the T-cell response to Mtv-7+ (AKR/J) than to Mtv-7 (C3H/HeN) stimulators. Treg cells from infected mice still displayed a certain degree of nonspecificity, as evidenced both by their ability to suppress MLR toward C3H/HeN APCs and by the fact that they were able to almost abrogate both the response to the SAg encoded by the Mtv-7 provirus and to MHC class II alloantigens expressed by AKR/J cells. Our data suggest that the SAg-cognate Treg cells that increase during infection preferentially suppress the proliferative response of T cells to SAg-expressing APCs.

The mechanisms underlying the ability of Treg cells from infected mice to preferentially suppress the T-cell response to SAg-expressing APCs remain unknown. Our unpublished results indicate that Treg cell suppression in the MLR requires cell contact. It has been postulated that Treg-cell interaction with DCs inhibits efficient antigen presentation to T effector cells (41). It has also been reported that Treg cells are able to down-modulate the expression of costimulatory molecules on DCs, diminishing their capacity to induce proliferation (47). Although other mechanisms cannot be discarded, taking into account that Treg cells which increase during MMTV infection are SAg specific and that AKR/J APCs express the Mtv-7 SAg on their surface, it is possible that cell contact between Treg cells and SAg-expressing APCs such as DCs inhibits the proliferative response in the MLR. However, it cannot be ruled out that other mechanisms may also be taking place in vivo, such as the production of inhibitory cytokines or the induction of indoleamine 2,3-dioxygenase (41, 47). In support of this, we did detect increased percentages of interleukin-10-producing PP CD4+ CD25+ cells (not shown).

To gain insight into the role of Treg cells during MMTV, infection we performed experiments depleting CD25+ cells. When CD25+ cells were depleted before the beginning of infection, significant increases in the number of PP SAg-cognate CD4+ Foxp3 Treg cells were measured. In addition, a slight increase in viral load was observed in the mesenteric lymph node and spleen of CD25-depleted mice. Even when the result was highly reproducible, the small difference detected in viral loads does not allow us to formally conclude that Treg cells affect viral load at the beginning of the infection. However, since the SAg response has been associated with viral amplification (1, 13), the possibility exists that Treg cells, by attenuating the SAg response, play a role in decreasing viral load at the beginning of the infection. On the other hand, when CD25+ cells were depleted once the initial SAg response had occurred, virus infection levels decreased at least 10-fold by the second generation. These results suggest that Treg cells favor an increase in virus infection levels at least from day 6 of infection onwards, probably by inhibiting an antiviral response, as has been suggested in other retroviral models (4, 5, 39, 46, 49). Even when the specificity of the Treg cells that favor the increase in viral load at this stage of infection cannot be established from our depletion experiments, it can be hypothesized that the interaction between SAg-specific Treg cells and infected APCs could lead to the generation of a tolerogenic microenvironment that could inhibit not only SAg-stimulated T-cell proliferation but also cytotoxic antiviral responses.

Our results are in agreement with the notion that during infection Treg cells may play a protective role in restraining host responses but may also be detrimental to the host, by dampening the immune responses necessary to avoid pathogen persistence (6). Of interest, it has been proposed that Treg cells may have a dual role in HIV pathogenesis, limiting the onset of immune activation that results in immune exhaustion and immune-mediated tissue damage and also contributing to the onset of immune dysfunction, especially of HIV-specific effector T cells (40).

It is notable that CD4+ CD25 Foxp3+ cells are not directly affected by administration of anti-CD25 antibody. Thus, the role of this population in MMTV infection remains to be determined.

It has been reported that the generation of Treg cells could favor the persistence of certain pathogens, but in the great majority of the cases it is unknown whether Treg cells are acting as the cause or the consequence of chronicity (40). Our data showed that MMTV was able to induce early increases in Treg cells, indicating that alterations in these cells were not the consequence of chronicity and strongly supporting the possibility that Treg cells may be playing a role in the cause of chronicity.

In summary, our results indicate that MMTV infection induces early and progressive increases in SAg-cognate CD4+ Foxp3+ Treg cells that are dependent on the presence of DCs. Treg cells would restrict the host responses to the virus at early times, thereby decreasing infection by a virus that requires lymphocyte activation to achieve efficient infection. However, at later stages the virus would be able to take advantage of these cells that are likely dampening a cytotoxic antiviral response. Thus, our results reveal that Treg cells play an important and complex role during MMTV infection.


arrow
ACKNOWLEDGMENTS
 
This work was supported by Fogarty International Research Collaboration Award PHS RO3 TW011103 (S.R.R. and I.P.) and ANPCYT PICT 506305, CONICET, and FUNDALEU.

We thank C. D. Pasqualini for helpful discussions. We also thank Antonio Morales for efficient technical assistance.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Instituto de Leucemia Experimental-Consejo Nacional de Investigaciones Científicas y Técnicas, División Medicina Experimental, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Pacheco de Melo 3081 (1425), Buenos Aires, Argentina. Phone: 54 11 4805 3411, ext. 287. Fax: 54 11 4803 9475. E-mail: ipiazzon{at}hematologia.anm.edu.ar Back

{triangledown} Published ahead of print on 21 May 2008. Back

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/. Back

{ddagger} G. C. and D. B. contributed equally to this work. Back


arrow
REFERENCES
 
    1
  1. Acha-Orbea, H., A. N. Shakhov, and D. Finke. 2007. Immune response to MMTV infection. Front. Biosci. 12:1594-1609.[CrossRef][Medline]
  2. 2
  3. Aluvihare, V. R., and A. G. Betz. 2006. The role of regulatory T cells in alloantigen tolerance. Immunol. Rev. 212:330-343.[CrossRef][Medline]
  4. 3
  5. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387-396.[Abstract/Free Full Text]
  6. 4
  7. Balkow, S., F. Krux, K. Loser, J. U. Becker, S. Grabbe, and U. Dittmer. 2007. Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells. Blood 110:3949-3958.[Abstract/Free Full Text]
  8. 5
  9. Beilharz, M. W., L. M. Sammels, A. Paun, K. Shaw, P. van Eeden, M. W. Watson, and M. L. Ashdown. 2004. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J. Immunol. 172:4917-4925.[Abstract/Free Full Text]
  10. 6
  11. Belkaid, Y., R. B. Blank, and I. Suffia. 2006. Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev. 212:287-300.[CrossRef][Medline]
  12. 7
  13. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.[Abstract/Free Full Text]
  14. 8
  15. Burzyn, D., J. C. Rassa, D. Kim, I. Nepomnaschy, S. R. Ross, and I. Piazzon. 2004. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78:576-584.[Abstract/Free Full Text]
  16. 9
  17. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature 350:203-207.[CrossRef][Medline]
  18. 10
  19. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Carcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-1764.[Abstract/Free Full Text]
  20. 11
  21. Courreges, M. C., D. Burzyn, I. Nepomnaschy, I. Piazzon, and S. R. Ross. 2007. Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J. Virol. 81:3769-3777.[Abstract/Free Full Text]
  22. 12
  23. Czarneski, J., P. Berguer, P. Bekinschtein, D. C. Kim, P. Hakimpour, N. Wagner, I. Nepomnaschy, I. Piazzon, and S. R. Ross. 2002. Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes. Eur. J. Immunol. 32:945-956.[CrossRef][Medline]
  24. 13
  25. Czarneski, J., J. C. Rassa, and S. R. Ross. 2003. Mouse mammary tumor virus and the immune system. Immunol. Res. 27:469-480.[CrossRef][Medline]
  26. 14
  27. Dittmer, U., H. He, R. J. Messer, S. Schimmer, A. R. Olbrich, C. Ohlen, P. D. Greenberg, I. M. Stromnes, M. Iwashiro, S. Sakaguchi, L. H. Evans, K. E. Peterson, G. Yang, and K. J. Hasenkrug. 2004. Functional impairment of CD8+ T cells by regulatory T cells during persistent retrovirus infection. Immunity 20:293-303.[CrossRef][Medline]
  28. 15
  29. Dujardin, H. C., O. Burlen-Defranoux, L. Boucontet, P. Vieira, A. Cumano, and A. Bandeira. 2004. Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells. Proc. Natl. Acad. Sci. USA 101:14473-14478.[Abstract/Free Full Text]
  30. 16
  31. Fehérvári, Z., and S. Sakaguchi. 2004. Control of Foxp3+ CD25+ CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16:1769-1780.[Abstract/Free Full Text]
  32. 17
  33. Feunou, P., L. Poulin, C. Habran, A. Le Moine, M. Goldman, and M. Y. Braun. 2003. CD4+ CD25+ and CD4+ CD25 T cells act, respectively, as inducer and effector T suppressor cells in superantigen-induced tolerance. J. Immunol. 171:3475-3484.[Abstract/Free Full Text]
  34. 18
  35. Fontenot, J. D., J. P. Rasmussen, L. M. William, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22:329-341.[CrossRef][Medline]
  36. 19
  37. Golovkina, T. V., A. B. Jaffe, and S. R. Ross. 1994. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:5019-5026.[Abstract/Free Full Text]
  38. 20
  39. Golovkina, T. V., I. Piazzon, I. Nepomnaschy, V. Buggiano, M. de Olano Vela, and S. R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:3895-3903.[Abstract]
  40. 21
  41. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.[CrossRef][Medline]
  42. 22
  43. Janeway, C. A., Jr., and M. E. Katz. 1985. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens. J. Immunol. 134:2057-2063.[Abstract]
  44. 23
  45. Joffre, O., N. Gorsse, P. Romagnoli, D. Hudrisier, and J. P. M. van Meerwijk. 2004. Induction of antigen-specific tolerance to bone marrow allografts with CD4+ CD25+ T lymphocytes. Blood 103:4216-4221.[Abstract/Free Full Text]
  46. 24
  47. Jude, B. A., Y. Pobezinskaya, J. Bishop, S. Parke, R. M. Medzhitov, A. V. Chervonsky, and T. V. Golovkina. 2003. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4:573-578.[CrossRef][Medline]
  48. 25
  49. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, E. G. Pamer, D. R. Littman, and R. A. Lang. 2002. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17:211-220.[CrossRef][Medline]
  50. 26
  51. Karapetian, O., A. N. Shakhov, J. P. Kraehenbuhl, and H. Acha-Orbea. 1994. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J. Exp. Med. 180:1511-1516.[Abstract/Free Full Text]
  52. 27
  53. Kim, J. M., and A. Rudensky. 2006. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 212:86-98.[CrossRef][Medline]
  54. 28
  55. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-1227.[CrossRef][Medline]
  56. 29
  57. Kretschmer, K., T. S. Heng, and H. von Boehmer. 2006. De novo production of antigen-specific suppressor cells in vivo. Nat. Protoc. 1:653-661.[CrossRef][Medline]
  58. 30
  59. Li, S., E. J. Gowans, C. Chougnet, M. Plebanski, and U. Dittmer. 2008. Natural regulatory T cells and persistent viral infection. J. Virol. 82:21-30.[Free Full Text]
  60. 31
  61. Long, T. T., S. Nakazawa, S. Onizuka, M. C. Huaman, and H. Kanbara. 2003. Influence of CD4+ CD25+ T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 33:175-183.[CrossRef][Medline]
  62. 32
  63. McGrath, C. M., S. Nandi, and L. Young. 1972. Relationship between organization of mammary tumors and the ability of tumor cells to replicate mammary tumor virus and to recognize growth-inhibitory contact signals in vitro. J. Virol. 9:367-376.[Abstract/Free Full Text]
  64. 33
  65. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
  66. 34
  67. Nesburn, A. B., I. Bettahi, G. Dasgupta, A. A. Chentoufi, X. Zhang, S. You, N. Morishige, A. J. Wahlert, D. J. Brown, J. V. Jester, S. L. Wechsler, and L. BenMohamed. 2007. Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J. Virol. 81:7647-7661.[Abstract/Free Full Text]
  68. 35
  69. Nishimura, E., T. Sakihama, R. Setoguchi, K. Tanaka, and S. Sakaguchi. 2004. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+ CD25+ CD4+ regulatory T cells. Int. Immunol. 16:1189-1201.[Abstract/Free Full Text]
  70. 36
  71. Pacholczyk, R., J. Kern, N. Singh, M. Iwashima, P. Kraj, and L. Ignatowicz. 2007. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 27:493-504.[CrossRef][Medline]
  72. 37
  73. Papiernik, M., M. Carmo Leite-de-Moraes, C. Pontoux, A. M. Joret, B. Rocha, C. Penit, and M. Dy. 1997. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10 producing T cell population with infectious capacity. J. Immunol. 158:4642-4653.[Abstract]
  74. 38
  75. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R Ross. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99:2281-2286.[Abstract/Free Full Text]
  76. 39
  77. Robertson, S. J., R. J. Messer, A. B. Carmody, and K. J. Hasenkrug. 2006. In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J. Immunol. 176:3342-3349.[Abstract/Free Full Text]
  78. 40
  79. Rouse, B. T., P. P. Sarangi, and S. Suvas. 2006. Regulatory T cells in virus infections. Immunol. Rev. 212:272-286.[CrossRef][Medline]
  80. 41
  81. Rudensky, A., and D. J. Campbell. 2006. In vivo sites and cellular mechanisms of Treg cell-mediated suppression. J. Exp. Med. 203:489-492.[Abstract/Free Full Text]
  82. 42
  83. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.[Abstract]
  84. 43
  85. Shevach, E. M. 2006. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25:195-201.[CrossRef][Medline]
  86. 44
  87. Subramanyam, M., B. McLellan, N. Labreque, R. P. Sekaly, and B. T. Huber. 1993. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J. Immunol. 151:2538-2545.[Abstract]
  88. 45
  89. Suffia, I. J., S. K. Reckling, C. A. Piccirillo, R. S. Goldszmid, and Y. Belkaid. 2006. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203:777-788.[Abstract/Free Full Text]
  90. 46
  91. Vahlenkamp, T. W., M. B. Tompkins, and W. A. Tompkins. 2004. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+ CD25+ T regulatory cells. J. Immunol. 172:4752-4761.[Abstract/Free Full Text]
  92. 47
  93. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338-344.[CrossRef][Medline]
  94. 48
  95. Walker, L. S. K., A. Chodos, M. Eggena, H. Dooms, and A. K Abbas. 2003. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198:249-258.[Abstract/Free Full Text]
  96. 49
  97. Weiss, L., V. Donkova-Petrini, L. Caccavelli, M. Balbo, C. Carbonneil, and Y. Levy. 2004. Human immunodeficiency virus-driven expansion of CD4+ CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249-3256.[Abstract/Free Full Text]
  98. 50
  99. Yamazaki, S., K. Inaba, K. V. Tarbell, and R. M. Steinman. 2006. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 212:314-329.[CrossRef][Medline]
  100. 51
  101. Yamazaki, S., M. Patel, A. Harper, A. Bonito, H. Fukuyama, M. Pack, K. V. Tarbell, M. Talmor, J. V. Ravetch, K. Inaba, and R. M. Steinman. 2006. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. USA 103:2758-2763.[Abstract/Free Full Text]
  102. 52
  103. Zelenay, S., T. Lopes-Carvalho, I. Caramalho, M. F. Moraes-fontes, M. Rebelo, and J. Demengeot. 2005. Foxp3+ CD25 CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA 102:4091-4096.[Abstract/Free Full Text]
  104. 53
  105. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-226.[CrossRef][Medline]


Journal of Virology, August 2008, p. 7422-7431, Vol. 82, No. 15
0022-538X/08/$08.00+0     doi:10.1128/JVI.00102-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrera, G.
Right arrow Articles by Piazzon, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrera, G.
Right arrow Articles by Piazzon, I.